Tristan Jernigan
Story Poster
11:31
Defense in Review feat. Sean Porter: Texas A&M 52, McNeese State 10
2 mo ago by Billy Liucci
A&M's first-team defense suffocated McNeese State the way the Aggies were expected to, as the visitors only scored 10 points in the second half against the Maroon & White reserves. Billy Liucci and Sean Porter break down the Ags' Week 2 defensive showing.
Story Poster
35:53
Lunch with Liucci: Billy Liucci joins TexAgs Radio (Monday, August 12)
3 mo ago by Billy Liucci
TexAgs co-owner and executive editor Billy Liucci joined TexAgs Radio on Monday morning to discuss all things surrounding college football as Texas A&M's fall camp continues. Liucci spoke on the latest injury report, Saturday's scrimmage and much more.
Story Poster
5:50
First trip to A&M leaves 'big' impression on 2026 LB Cincere Johnson
3 mo ago by Jason Howell
After receiving an offer from Texas A&M in May, 2026 Cleveland (OH) Glenville linebacker Cincere Johnson made his first visit to Aggieland over the weekend. Following the trip. Johnson spoke to TexAgs about what stood out, his recruitment process and much more.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
5:04
Long-time commit Kelvion Riggins recruiting hard for the Aggies
5 mo ago by Jason Howell
In the boat since January, Forney 2025 linebacker and Texas A&M commit Kelvion Riggins returned to Aggieland this weekend with the intention of growing the class. After his time in College Station, he spoke about who he is recruiting, some fun activities and much more.
Story Poster
A&M's defense will be guided even more by York's leadership in 2024
7 mo ago by Olin Buchanan
In 2023, freshman linebacker Taurean York impressed many nationwide, becoming a freshman All-American after being a three-star prospect coming out of high school. This year, York projects to have an even more significant role in the Texas A&M defense.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.